Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - RESEARCH & DEVELOPMENT
Research & Development CRVS - Corvus Pharmaceuticals, Inc.
16.5 M
LAST VALUE
-24.66%
2 YEAR CAGR
-15.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR